CU24134B1 - Nuevos derivados dihidro-oxazolobenzodiazepinonas, y las composiciones farmacéuticas que los contienen - Google Patents
Nuevos derivados dihidro-oxazolobenzodiazepinonas, y las composiciones farmacéuticas que los contienenInfo
- Publication number
- CU24134B1 CU24134B1 CUP2012000041A CU20120041A CU24134B1 CU 24134 B1 CU24134 B1 CU 24134B1 CU P2012000041 A CUP2012000041 A CU P2012000041A CU 20120041 A CU20120041 A CU 20120041A CU 24134 B1 CU24134 B1 CU 24134B1
- Authority
- CU
- Cuba
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- new
- oxazolobenzodiazepinonas
- dihidro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a nuevos compuestos dihidro-oxazolobenzodiazepinone de fórmula (I): ESPACIO PARA LA FÓRMULA en la que: R1 representa un átomo de hidrógeno o un grupo alquilo; R2 representa un grupo alquilo y R3 representa un grupo arilo o heteroarilo; a un procedimiento para su preparación y a composiciones farmacéuticas que los contienen. Los compuestos de la presente invención son selectivos de la subunidad alfa5 del receptor GABAA y disminuyen los efectos del neurotransmisor GABA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1100682A FR2972454B1 (fr) | 2011-03-08 | 2011-03-08 | Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20120041A7 CU20120041A7 (es) | 2013-10-29 |
CU24134B1 true CU24134B1 (es) | 2015-11-27 |
Family
ID=44004482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CUP2012000041A CU24134B1 (es) | 2011-03-08 | 2012-03-08 | Nuevos derivados dihidro-oxazolobenzodiazepinonas, y las composiciones farmacéuticas que los contienen |
Country Status (44)
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230684B1 (en) * | 2014-01-21 | 2017-08-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | New dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
DE102016005291B4 (de) | 2016-04-29 | 2024-01-11 | Ksg Austria Gmbh | Verfahren zur Herstellung eines elektronischen Gerätes in der Form eines Spritzgußteils mit eingelegter Leiterplatte |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3370616D1 (en) | 1982-08-06 | 1987-05-07 | Ube Industries | Process for producing phenylacetones |
US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
EP1015457B1 (en) * | 1997-08-12 | 2003-11-26 | Egis Gyogyszergyar Rt. | 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors |
UA67749C2 (uk) * | 1997-08-12 | 2004-07-15 | Егіш Дьйодьсердьяр Рт. | Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування |
GB9900222D0 (en) * | 1999-01-06 | 1999-02-24 | Merck Sharp & Dohme | Therapeutic compounds |
HU227128B1 (en) * | 1999-07-07 | 2010-07-28 | Egyt Gyogyszervegyeszeti Gyar | New 2,3-benzodiazepine derivatives |
WO2007050587A2 (en) * | 2005-10-26 | 2007-05-03 | The Regents Of The University Of Michigan | Therapeutic compositions and methods |
HU230760B1 (hu) * | 2005-12-30 | 2018-03-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Dihidro-2,3-benzodiazepin-származékok optikai izomerjei, eljárás ezek sztereoszelektív szintézisére, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények és az eljárás közbenső termékei |
EP2298296A1 (en) * | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
-
2011
- 2011-03-08 FR FR1100682A patent/FR2972454B1/fr active Active
-
2012
- 2012-02-20 IL IL218215A patent/IL218215A/en active IP Right Grant
- 2012-02-21 JO JO201236A patent/JO2948B1/en active
- 2012-02-22 PE PE2012000242A patent/PE20121682A1/es active IP Right Grant
- 2012-02-22 SG SG2012012340A patent/SG184633A1/en unknown
- 2012-02-22 AU AU2012201031A patent/AU2012201031B2/en not_active Ceased
- 2012-02-24 MY MYPI2012700036A patent/MY162537A/en unknown
- 2012-02-27 CL CL2012000496A patent/CL2012000496A1/es unknown
- 2012-02-28 UY UY0001033927A patent/UY33927A/es unknown
- 2012-03-02 MA MA34658A patent/MA33641B1/fr unknown
- 2012-03-05 CA CA2771189A patent/CA2771189C/fr not_active Expired - Fee Related
- 2012-03-05 GE GEAP201212613A patent/GEP20146017B/en unknown
- 2012-03-06 CR CR20120109A patent/CR20120109A/es unknown
- 2012-03-06 EC ECSP12011711 patent/ECSP12011711A/es unknown
- 2012-03-06 MX MX2012002788A patent/MX2012002788A/es active IP Right Grant
- 2012-03-06 AP AP2012006149A patent/AP3344A/xx active
- 2012-03-07 BR BRBR102012005137-0A patent/BR102012005137A2/pt not_active Application Discontinuation
- 2012-03-07 PT PT122900772T patent/PT2497774E/pt unknown
- 2012-03-07 AR ARP120100728A patent/AR085691A1/es unknown
- 2012-03-07 US US13/413,977 patent/US8778932B2/en not_active Expired - Fee Related
- 2012-03-07 NI NI201200039A patent/NI201200039A/es unknown
- 2012-03-07 ZA ZA2012/01681A patent/ZA201201681B/en unknown
- 2012-03-07 JP JP2012050550A patent/JP5475816B2/ja not_active Expired - Fee Related
- 2012-03-07 DK DK12290077.2T patent/DK2497774T3/da active
- 2012-03-07 SA SA112330231A patent/SA112330231B1/ar unknown
- 2012-03-07 WO PCT/FR2012/000080 patent/WO2012120206A1/fr active Application Filing
- 2012-03-07 RU RU2013144824/04A patent/RU2572556C2/ru not_active IP Right Cessation
- 2012-03-07 SA SA112330331A patent/SA112330331B1/ar unknown
- 2012-03-07 HN HN2012000485A patent/HN2012000485A/es unknown
- 2012-03-07 EA EA201200267A patent/EA021125B1/ru not_active IP Right Cessation
- 2012-03-07 EP EP12290077.2A patent/EP2497774B1/fr active Active
- 2012-03-07 NZ NZ598625A patent/NZ598625A/xx not_active IP Right Cessation
- 2012-03-07 UA UAA201202760A patent/UA112153C2/uk unknown
- 2012-03-07 SI SI201230017T patent/SI2497774T1/sl unknown
- 2012-03-07 ES ES12290077.2T patent/ES2442293T3/es active Active
- 2012-03-07 PL PL12290077T patent/PL2497774T3/pl unknown
- 2012-03-07 TW TW101107763A patent/TWI428342B/zh not_active IP Right Cessation
- 2012-03-07 RS RS20130492A patent/RS53032B/en unknown
- 2012-03-08 CU CUP2012000041A patent/CU24134B1/es unknown
- 2012-03-08 KR KR1020120023935A patent/KR101477991B1/ko active IP Right Grant
- 2012-03-08 CN CN201210063418.8A patent/CN102675341B/zh not_active Expired - Fee Related
- 2012-03-08 GT GT201200066A patent/GT201200066A/es unknown
-
2013
- 2013-03-18 HK HK13103337.1A patent/HK1176355A1/xx not_active IP Right Cessation
- 2013-12-13 CY CY20131101128T patent/CY1114729T1/el unknown
-
2014
- 2014-01-16 HR HRP20140050AT patent/HRP20140050T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018000730A1 (es) | Compuestos heterocíclicos y usos de los mismos | |
CU24309B1 (es) | Compuestos derivados tienopirimidina y composiciones farmacéuticas que los contienen | |
CR20150045A (es) | Inhibidores de hepatitis c | |
CR20170564A (es) | Nuevos derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
CR20140042A (es) | Indazoles | |
PE20151997A1 (es) | Compuestos heterociclicos y usos de los mismos | |
CR20140133A (es) | Compuestos de piridazinona y sus usos como inhibidores de daao | |
CR20170571A (es) | Nuevos derivados aminoácido, un proceso para su preparación y composiciones farmaceúticas que los contienen. | |
CR20140464A (es) | Compuestos de heterociclilo | |
PE20160661A1 (es) | Compuesto de azapiridona y sus usos de los mismos | |
UY35469A (es) | Moduladores de p2x7 | |
SV2014004770A (es) | Nuevos derivados de pirrol, su procedimiento de preparación y los composiciones farmacéuticas que los contienen | |
EA201500426A1 (ru) | Производные пирролотриазинона в качестве ингибиторов pi3k | |
CR20130118A (es) | DERIVADOS DE PIRAZINA COMO BLOQUEADORES DE ENaC | |
CR20140435A (es) | Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos | |
UY35447A (es) | Moduladores de p2x7 | |
CR20120234A (es) | Derivados de sulfonamida heterocíclicos útiles como inhibidores de mek | |
CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CR20110484A (es) | Nuevos derivados de benzotiazepinas su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
CU20180028A7 (es) | DERIVADOS DE IMIDAZO[4,5-b]PIRIDINA, ÚTILES COMO INHIBIDORES DUALES DE DYRK1/CLK1 Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN | |
EA201391797A1 (ru) | 3-спироциклические пиперидиновые производные в качестве агонистов грелиновых рецепторов | |
ECSP13013016A (es) | Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, y su uso como inhibidores de la cinasa del receptor vegf | |
ECSP13012914A (es) | Síntesis de derivados de 2-carboxamida-cicloamino-urea | |
CU24134B1 (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, y las composiciones farmacéuticas que los contienen | |
AR093168A1 (es) | COMPUESTOS DE OXAZOLIDINONA COMO INHIBIDORES DEL CANAL KCa3.1 |